1. Italy Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Safilo Group S.p.A.

Safilo Group S.p.A.

SAFLF
Safilo Group S.p.A.US flagOther OTC
2.31
USD
+0.07
- -
906.63MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
10.12
10.53
11.4
11.15
9.21
7.6
3.07
2.83
3.25
2.6
2.49
2.41
2.37
11.43
Basic EPS, GAAP
0.14
0.35
-0.47
-1.27
-2.24
-0.27
-1.07
-0.26
0.07
0.13
-0.06
0.05
0.12
-0.47
Free Cash Flow per Basic Share
0.29
-0.11
0.6
0.33
-0.63
-0.17
0.01
-0.06
0.01
-0.01
0.09
0.16
0.2
0.6
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
3.26
4.35
4.56
3.45
0.43
0.54
-0.82
-1.64
-1.23
-0.69
0.86
0.93
0.88
4.57
Tangible Book Value per Share
2.36
3
3.14
3.21
2.21
3.02
0.96
0.03
0.64
0.66
0.62
0.62
0.62
3.15
Basic Weighted Avg Shares
111
112
112
112
112
120
306
276
298
414
411
413
414
112
Sales/Revenue/Turnover
1,122
1,179
1,279
1,253
1,035
911
939
780
970
1,077
1,025
993
983
1,279
Operating Margin (%)
7.62
7.05
4.76
3.75
- -
1.75
-1.84
-9.8
1.63
3.5
-0.34
2.87
4.79
4.87
Depreciation Expense
37
35
41
47
42
48
77
59
53
48
55
40
38
41
Net Income, GAAP
16
39
-53
-142
-252
-32
-328
-73
21
54
-25
22
49
-53
Effective Tax Rate (%)
68.09
39.17
- -
- -
- -
- -
- -
- -
42.49
18.38
- -
31.2
28.01
149.49
Profit Margin (%)
1.38
3.31
-4.12
-11.34
-24.3
-3.56
-34.96
-9.35
2.19
5.03
-2.41
2.24
4.95
-4.12
Working Capital
249
277
278
274
184
169
233
192
251
284
259
233
186
278
LT Debt
191
176
133
137
142
- -
110
278
165
152
118
90
58
133
Total Equity
846
974
999
873
533
646
342
182
366
439
396
427
403
999
Return on Invested Capital (%)
2.46
4.35
- -
- -
- -
- -
- -
- -
1.72
5.12
- -
3.48
6.41
9.54
Return on Capital (%)
2.97
6.54
- -
- -
- -
- -
- -
- -
-26.05
-63.86
- -
5.64
10.81
4.56
Return on Common Equity (%)
4.2
9.21
-10.56
-31.58
-115.31
-57.13
- -
- -
- -
- -
- -
6.05
12.98
-10.56

Capital Structure

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
ST Debt
60
48
44
LT Borrowings
130
131
133
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
112
112
112
Market Capitalization
1,564
1,543
1,195

Working Capital

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
Total Current Assets
663
619
640
Cash, Cash Equivalents & STI
81
84
88
Accounts Receivable, Net
280
228
244
Inventories
248
255
254
Total Current Liabilities
369
330
362
Payables & Accruals
- -
- -
- -
ST Debt
60
48
44
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.09%
22.63%
-5.71%
Free Cash Flow
-248.03%
-270.47%
25.72%
Net Income, GAAP
80.09%
-38.48%
118.15%
Sales/Revenue/Turnover
-1.88%
5.28%
-0.99%
Total Cash Common Dividend
- -
- -
-62.52%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,025
2024
- -
- -
- -
- -
993
2025
- -
- -
- -
- -
983

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.06
2024
- -
- -
- -
- -
0.05
2025
- -
- -
- -
- -
0.12

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

MCPAPIChat
CEO
Angelo Trocchia
Full Time Employees
3,352
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
Settima Strada 15 Padua PD Italy 35129
IPO Date
Oct 15, 2010
CIK
0001538028
Website
safilogroup.com
Similar Companies
Qatari German Company for Medical Devices (Q.P.S.C.) (QGMD.QA)
Top Glove Corporation Bhd. (7113.KL)
Shanghai Kindly Enterprise Development Group Co.,LTD. (603987.SS)
Wearable Health Solutions, Inc. (WHSI)
Kaisa Health Group Holdings Limited (0876.HK)
Fisher & Paykel Healthcare Corporation Limited (FSPKF)
Business
Safilo Group S.p.A. (SAFLF) designs, manufactures, and distributes prescription eyewear frames, sunglasses, and sports eyewear worldwide. The company offers an extensive portfolio of products under its owned brands, including Carrera, Polaroid, Safilo, Seventh Street, and Privé Revaux, as well as licensed brands such as Hugo Boss, Jimmy Choo, Kate Spade, Marc Jacobs, Missoni, and under license agreements with major names like Armani, Bulgari, Dior, Fendi, and Gucci; it provides complete eyewear solutions encompassing ophthalmic frames, sunglasses, reading glasses, and accessories for men, women, and children. Safilo operates through a vertically integrated model with manufacturing facilities in Italy, China, and Vietnam, serving opticians, wholesalers, and retailers across more than 100 countries, with a primary focus on Europe, North America, and Asia-Pacific markets. Founded in 1934 and headquartered in Padua, Italy, the company maintains subsidiaries in key regions including the United States, France, and Australia to support its global distribution network. In recent developments, Safilo launched new collections under its Carrera brand featuring advanced sustainable materials and partnered strategically with eyewear retailers to expand digital sales channels; the company also completed a refinancing of its debt structure in 2024 and announced operational optimizations in its Asian manufacturing sites to enhance efficiency amid supply chain shifts.